Vitiligo is a chronic autoimmune condition, and achieving repigmentation through 308nm phototherapy is a significant milestone. However, one of the most common concerns patients have is: will the color last after I stop treatment? Here's what the research reveals about long-term outcomes.

Relapse Is Common, But Not Inevitable

Without maintenance therapy, relapse after successful repigmentation occurs in about 40% of cases following discontinuation of treatment. Across phototherapy and topical regimens, approximately 40–50% of patients begin to lose acquired color within two years after successful repigmentation.

A 2007 follow-up study of 31 patients with generalized vitiligo who achieved >75% repigmentation with narrowband UVB found that only five patients (16%) maintained stable repigmentation two years after stopping treatment. Notably, four out of six relapses occurred within the first six months post-treatment. Another study reported that repigmentation was stable in only 14.3% of patients four years after cessation of treatment.

Encouraging Long-Term Data

Despite these figures, there is reason for optimism. A 2025 retrospective study of 176 patients with non-segmental vitiligo treated with NB-UVB found that 80 patients (45%) achieved clinically significant repigmentation (≥50%). Among these responders, 76 patients (95%) maintained their response for at least six months after treatment discontinuation, and strikingly, 47 patients (59%) sustained repigmentation for more than six years.

Factors That Influence Durability

Several key factors are associated with long-term repigmentation:

Achieving a robust response: Patients who reach ≥50% repigmentation are significantly more likely to maintain their results.
Prolonged treatment duration: Treatment courses lasting longer than 18 months are associated with better durability.
Higher cumulative radiation dose: Cumulative doses exceeding 356 J/cm² are tied to more durable outcomes.
Body site: The face and trunk are most stable, while hands, feet, and bony prominences relapse faster.

Maintenance Therapy: The Key to Lasting Results

The single most effective strategy for preventing relapse is implementing a maintenance regimen after successful repigmentation. The 2025 Canadian Consensus Guidelines for the Management of Vitiligo specifically states that maintenance therapy may help mitigate the risk of disease relapse.

Effective maintenance options include:

Topical tacrolimus (0.1% ointment) applied twice weekly: Studies show this can decrease the relapse rate to around 9%. Topical corticosteroids applied twice weekly may work similarly.
Gradual step-down of phototherapy: A consensus of 15–20 international centers recommends reducing phototherapy frequency stepwise: from three times weekly to twice weekly for one month, then to once weekly for one month, then to once every other week for two months. If no relapse occurs, treatment can be discontinued.

Realistic Expectations

Vitiligo is a chronic, relapsing condition. Even with the best outcomes, some patients will experience recurrence over time. Longer horizons show up to 50–75% relapse within 3–5 years, especially when no maintenance therapy is used. However, patients who achieve a clinically significant response, undergo prolonged treatment, and adhere to a maintenance plan have a genuine chance at long-term stability.

The Bottom Line

Yes, vitiligo can return after stopping phototherapy, but the risk can be significantly reduced. Achieving ≥50% repigmentation, completing an adequate course of treatment, and following a structured maintenance regimen-whether with twice-weekly topical tacrolimus or gradually tapered phototherapy—offers the best chance for lasting color. As the 2025 Canadian guidelines emphasize, maintenance therapy is not optional for those who want to preserve their results. It is an essential component of long-term vitiligo management.

Does Vitiligo Come Back After Stopping Phototherapy? Long-term Outlook

Get the latest price?